Galapagos
Europe, Limburg, Belgium, Mechelen-bovelingen
Description
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Investor Profile
Galapagos has backed more than 3 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series C rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands, France.
- Strong thematic focus on Biotechnology, Life Science, Biopharma.
Stage Focus
- Seed (67%)
- Series C (33%)
Country Focus
- United States (33%)
- The Netherlands (33%)
- France (33%)
Industry Focus
- Biotechnology
- Life Science
- Biopharma
- Pharmaceutical
- Precision Medicine
- Health Care
- Therapeutics
- Health Diagnostics
- Medical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
